Trump Ends Sas Hiv And Tb Research Grants
Cancellation letters, which end millions of rands of South African universities US-government funded HIV and TB research grants with immediate effect, started to roll in over the weekend.
On Friday evening, the University of the Witwatersrands Wits Health Consortium received a cancellation letter for a grant of 943 730 R17.1-million, run by researchers Helen Rees and Ian Sanne.
Several other internationally acclaimed researchers have reportedly also had their study grants terminated.
Fears are rife that the Trump administration might stop all US government grants, which holds devastating implications for South Africa.
Some experts estimate that as much as 70 of the countrys HIV and TB research is funded through the US governments National Institutes of Health.
In todays newsletter , Mia Malan explains that South African universities have received cancellation letters confirming the end of their US-government funded HIV and TB research grants. Sign up for our newsletter today.
This is a developing story that will be updated as new information becomes available.
Cancellation letters, which end millions of rands of South African universities US-government funded HIV and TB research grants with immediate effect, started to roll in over the weekend and fears are rife that the Trump administration might stop all grants, which holds devastating implications for South Africa.
Some experts estimate that as much as 70 of South Africas HIV and TB research is funded through the National Institutes of Health NIH, which is made up of 27 institutes and centres that each focuses on a specific area of research. The NIH finances about three-quarters of biomedical research worldwide.
On Friday evening, the University of the Witwatersrands Wits Health Consortium , the unit through which the institution runs its clinical trials and donor-funded projects, received a cancellation letter for a grant of 943 730 R17.1-million for which the current budget started on December 1 2024 and ends on November 30 2025. The grant was awarded through the NIHs National Institute for Allergies and Infectious Diseases .